Showing 381-390 of 10581 results for "".
A Landmark Surgery That Saved Three Children With One Heart
https://reachmd.com/programs/medical-industry-feature/a-landmark-surgery-that-saved-three-children-with-one-heart/29917/Discover how an advanced surgical approach used one donor heart to save three lives in an unprecedented pediatric operation.The Future of PI3K Inhibition in HR+/HER2- Breast Cancer
https://reachmd.com/programs/cme/The-Future-of-PI3K-Inhibition-in-HR-HER2-Breast-Cancer/37339/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Chairperson’s Perspective: Precision in Practice: Advancing EGFR-Altered Metastatic NSCLC Through Guideline-Concordant, Case-Based Learning
https://reachmd.com/programs/cme/chairpersons-perspective-precision-in-practice-advancing-egfr-altered-metastatic-nsclc-through-guideline-concordant-case-based-learning/33808/Improve patient outcomes in EGFR-mutated metastatic NSCLC through timely molecular testing, evidence-based treatment, and team-based management of AEs.The Alloimmune Disorders of Pregnancy
https://reachmd.com/programs/cme/the-alloimmune-disorders-of-pregnancy/32274/FNAIT is the platelet equivalent of Rh disease. Managing this alloimmune disorder of pregnancy poses many challenges for clinicians. Learn more here!Current Standards and Future Opportunities for ADCs in Advanced/Metastatic Triple-Negative Breast Cancer
https://reachmd.com/programs/cme/current-standards-and-future-opportunities-for-adcs-in-advancedmetastatic-triple-negative-breast-cancer/14551/Are you ready and willing to change your treatment approach for your patients with TNBC? Our experts break down the guidelines to get you on track.Alloimmune Thrombocytopenia in the Fetus and Newborn
https://reachmd.com/programs/cme/alloimmune-thrombocytopenia-in-the-fetus-and-newborn/13909/In severe cases, FNAIT can lead to fetal intracranial hemorrhage. How can you lower risks for your patients facing this uncommon disorder?Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
https://reachmd.com/programs/cme/parallels-between-kidney-transplantation-and-maternal-anti-fetal-rejection/13911/Get below the surface and explore what kidney transplantation & maternal anti-fetal rejection have in common. The answer could change your practice.Implementing the Latest Diagnostic and Treatment Approaches for Generalized Myasthenia Gravis
https://reachmd.com/programs/cme/implementing-the-latest-diagnostic-and-treatment-approaches-for-generalized-myasthenia-gravis/32961/Examine FcRn inhibitors in gMG with expert discussion on mechanisms, clinical trial results, therapeutic use, and individualized treatment approaches.Practical Perspectives in Myasthenia Gravis #2: Patient Stratification and Antibody Profiling—Personalizing the Disease Lens
https://reachmd.com/programs/cme/gmg-patient-stratification-and-antibody-profiling-personalizing-the-disease-lens/39029/Examine how antibody testing and patient characteristics inform personalized care when managing generalized myasthenia gravis.Epilepsy Essentials: Novel Interictal Biomarkers for Delineating the Epileptogenic Zone in Children With Drug-Resistant Epilepsy
https://reachmd.com/programs/practical-neurology-focus-on-epilepsy-seizures/epilepsy-essentials-novel-interictal-biomarkers-for-delineating-the-epileptogenic-zone-in-children-with-drug-resistant-epilepsy/32147/Novel interictal biomarkers of epilepsy are able to identify the epileptogenic zone with precision and predict surgical outcome in children with drug-resistant epilepsy.